One Hundred Lawmakers Urge HHS to Help Lower Prescription Drug Prices

In a letter to HHS Secretary Xavier Becerra, 100 members of Congress called for the use of several controversial federal authorities — including compulsory licensing, “march-in rights” and royalty-free rights — to help lower the prices of prescription drugs. Source: Drug Industry Daily

Read More

Uveitis Prompts Partial Clinical Hold on Nuvation Bio Cancer Drug

Uveitis — an inflammation of the middle layer of the eye — in treated patients has prompted FDA to halt enrollment in Nuvation Bio’s phase 1/2 dose-escalation study of NUV-422, a checkpoint inhibitor under investigation for a wide variety of solid tumors. Source: Drug Industry Daily

Read More